• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对日间过度嗜睡患者的推荐治疗策略。

Recommended treatment strategies for patients with excessive daytime sleepiness.

作者信息

Rosenberg Russell P

机构信息

From NeuroTrials Research and the Atlanta School of Sleep Medicine and Technology, Georgia.

出版信息

J Clin Psychiatry. 2015 Oct;76(10):e1330. doi: 10.4088/JCP.14019tx3c.

DOI:10.4088/JCP.14019tx3c
PMID:26528660
Abstract

Excessive daytime sleepiness (EDS) is a common and bothersome phenomenon. It can be associated with insufficient sleep syndrome, narcolepsy, idiopathic hypersomnia, obstructive sleep apnea, shift work disorder, Kleine-Levin syndrome, or Parkinson's disease. Once the underlying cause of the excessive sleepiness is determined, clinicians must select the most appropriate behavioral and pharmacologic interventions to reduce daytime sleepiness, alleviate other symptoms, improve functioning, and ensure the safety of patients and those around them. Patient history, adverse effects, and efficacy in specific conditions should be considered in pharmacologic treatment options for patients with EDS.

摘要

白天过度嗜睡(EDS)是一种常见且令人困扰的现象。它可能与睡眠不足综合征、发作性睡病、特发性嗜睡症、阻塞性睡眠呼吸暂停、轮班工作障碍、克莱恩-莱文综合征或帕金森病有关。一旦确定了过度嗜睡的潜在原因,临床医生必须选择最合适的行为和药物干预措施,以减少白天嗜睡、缓解其他症状、改善功能,并确保患者及其周围人的安全。对于患有EDS的患者,在药物治疗选择中应考虑患者病史、不良反应以及特定情况下的疗效。

相似文献

1
Recommended treatment strategies for patients with excessive daytime sleepiness.针对日间过度嗜睡患者的推荐治疗策略。
J Clin Psychiatry. 2015 Oct;76(10):e1330. doi: 10.4088/JCP.14019tx3c.
2
Narcolepsy and syndromes of primary excessive daytime somnolence.发作性睡病与原发性日间过度嗜睡综合征。
Semin Neurol. 2004 Sep;24(3):271-82. doi: 10.1055/s-2004-835069.
3
Idiopathic Hypersomnia and Kleine-Levin Syndrome: Primary Disorders of Hypersomnolence Beyond Narcolepsy.特发性嗜睡症和克莱恩-莱文综合征:发作性睡病以外的原发性过度嗜睡障碍
Semin Pediatr Neurol. 2023 Dec;48:101082. doi: 10.1016/j.spen.2023.101082. Epub 2023 Sep 14.
4
Recent advances in the treatment and management of excessive daytime sleepiness.日间过度嗜睡治疗与管理的最新进展
CNS Spectr. 2007 Feb;12(2 Suppl 2):1-14; quiz 15. doi: 10.1017/s1092852900028376.
5
Narcolepsy and other causes of excessive daytime sleepiness.发作性睡病及其他导致日间过度嗜睡的原因。
Respir Care Clin N Am. 1999 Sep;5(3):427-46, viii-ix.
6
Disorders of excessive sleepiness: narcolepsy and hypersomnia.过度嗜睡症:发作性睡病和特发性嗜睡症。
Semin Neurol. 1987 Sep;7(3):250-8. doi: 10.1055/s-2008-1041425.
7
Daytime sleepiness in children: When a quiet child is not necessarily a good thing.儿童日间嗜睡:安静的孩子未必是好事。
Paediatr Respir Rev. 2018 Jan;25:1-2. doi: 10.1016/j.prrv.2017.01.002. Epub 2017 Jan 19.
8
Excessive daytime sleepiness.日间过度嗜睡。
Am Fam Physician. 2009 Mar 1;79(5):391-6.
9
Excessive Daytime Sleepiness: A Clinical Review.日间过度嗜睡:临床综述。
Mayo Clin Proc. 2021 May;96(5):1288-1301. doi: 10.1016/j.mayocp.2020.08.033. Epub 2021 Apr 9.
10
Excessive daytime sleepiness in narcolepsy and central nervous system hypersomnias.发作性睡病和中枢神经系统嗜睡症中的日间过度嗜睡。
Sleep Breath. 2020 Jun;24(2):605-614. doi: 10.1007/s11325-019-01867-7. Epub 2019 Jun 1.

引用本文的文献

1
Natural Cannabinoids as Templates for Sleep Disturbances Treatments.天然大麻素作为治疗睡眠障碍的模板。
Adv Exp Med Biol. 2021;1297:133-141. doi: 10.1007/978-3-030-61663-2_9.
2
Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea.在伴有嗜睡症或阻塞性睡眠呼吸暂停的患者中,使用索里昂(JZP-110)治疗过度嗜睡的安全性和疗效维持的长期研究。
Sleep. 2020 Feb 13;43(2). doi: 10.1093/sleep/zsz220.
3
A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor.
一项随机、双盲、安慰剂对照、交叉研究,旨在评估选择性多巴胺和去甲肾上腺素再摄取抑制剂索利那新的人体滥用倾向。
J Psychopharmacol. 2018 Dec;32(12):1351-1361. doi: 10.1177/0269881118796814. Epub 2018 Oct 1.
4
Capacity of the Edmonton Symptom Assessment System and the Canadian Problem Checklist to screen clinical insomnia in cancer patients.埃德蒙顿症状评估系统和加拿大问题清单筛查癌症患者临床失眠症的能力。
Support Care Cancer. 2016 Oct;24(10):4339-44. doi: 10.1007/s00520-016-3273-4. Epub 2016 May 18.